Rankings
▼
Calendar
ARCT Q1 2022 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+146.5% YoY
Gross Profit
-$40M
-756.1% margin
Operating Income
-$50M
-960.7% margin
Net Income
-$51M
-975.8% margin
EPS (Diluted)
$-1.97
QoQ Revenue Growth
-9.5%
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$51M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$342M
Total Liabilities
$157M
Stockholders' Equity
$185M
Cash & Equivalents
$320M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$2M
+146.5%
Gross Profit
-$40M
-$48M
+17.3%
Operating Income
-$50M
-$58M
+12.6%
Net Income
-$51M
-$56M
+9.2%
← FY 2022
All Quarters
Q2 2022 →